The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: A prospective study

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ye, Ying ^a,d   Carlsson, Göran ^b   Karlsson Sjöberg, Jenny M T ^a   Borregaard, Niels ^c   Modéer, Thomas U ^a   Andersson, Mats L ^a   Pütsep, Katrin L A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Rigshospitalet   (Denmark)

^d PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ADOLESCENT; ADULT; BLOOD; CHILD; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INFANT; LEUKOCYTE COUNT; MALE; NEUTROPENIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT; LEUKOCYTE COUNT; MALE; NEUTROPENIA; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84934324610     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11685     Document Type: Article

References (42)

1. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6, 173-182 (2006).
2. Boxer, L. A. How to approach neutropenia. Hematology Am Soc Hematol Educ Program 2012, 174-182 (2012).
3. Donadieu, J., Fenneteau, O., Beaupain, B., Mahlaoui, N. & Chantelot, C. B. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 6, 26 (2011).
4. Niemeyer, C. M. & Baumann, I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program 2011, 84-89 (2011).
5. Walkovich, K. & Boxer, L. A. How to approach neutropenia in childhood. Pediatr Rev 34, 173 (2013).
6. Angelino, G. et al. Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases. Pediatr Allergy Immunol 25, 283-289 (2014).
7. Kostmann, R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 45, 1-78 (1956).
8. Carlsson, G. et al. Kostmann syndrome or infantile genetic agranulocytosis, part one: celebrating 50 years of clinical and basic research on severe congenital neutropenia. Acta Paediatr 95, 1526-1532 (2006).
9. Aprikyan, A. A. et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95, 320-327 (2000).
10. Klein, C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol 29, 399-413 (2011).
11. Boztug, K. & Klein, C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr 23, 21-26 (2011).
12. Xia, J. et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 147, 535-542 (2009).
13. Zeidler, C., Germeshausen, M., Klein, C. & Welte, K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 144, 459-467 (2009).
14. Pötsep, K., Carlsson, G., Boman, H. G. & Andersson, M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149 (2002).
15. Karlsson, J., Carlsson, G., Larne, O., Andersson, M. & Putsep, K. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia. J Leukoc Biol 84, 1279-1286 (2008).
16. Sorensen, O., Cowland, J. B., Askaa, J. & Borregaard, N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206, 53-59 (1997).
17. Karlsson, J. et al. Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. Br J Haematol 137, 166-169 (2007).
18. Agerberth, B. et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92, 195-199 (1995).
19. Sorensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F. & Borregaard, N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803 (1997).
20. Barth, P. G. et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62, 327-355 (1983).
21. Makaryan, V. et al. The cellular and molecular mechanisms for neutropenia in Barth syndrome. Eur J Haematol 88, 195-209 (2012).
22. Boocock, G. R. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 33, 97-101 (2003).
23. Tulpule, A. et al. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell 12, 727-736 (2013).
24. Kivitie-Kallio, S. & Norio, R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet 102, 125-135 (2001).
25. Duplomb, L. et al. Cohen syndrome is associated with major glycosylation defects. Hum Mol Genet 23, 2391-2399 (2014).
26. Stepensky, P. et al. The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood 121, 5078-5087 (2013).
27. Kivitie-Kallio, S., Rajantie, J., Juvonen, E. & Norio, R. Granulocytopenia in Cohen syndrome. Br J Haematol 98, 308-311 (1997).
28. Ye, Y. et al. Pretherapeutic plasma proand antiinflammatory mediators are related to high risk of oral mucositis in pediatric patients with acute leukemia: a prospective cohort study. PLoS One 8, e64918, doi: 10.1371/journal.pone.0064918 (2013).
29. Perreault, S., Bernard, G., Lortie, A., Le Deist, F. & Decaluwe, H. Ataxia-Telangiectasia presenting with a novel immunodeficiency. Pediatr Neurol 46, 322-324 (2012).
30. Manganelli, G., Masullo, U., Passarelli, S. & Filosa, S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets 13, 73-82 (2013).
31. Menconi, F., Marcocci, C. & Marino, M. Diagnosis and classification of Graves disease. Autoimmun Rev 13, 398-402 (2014).
32. Sundin, M. et al. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology. J Clin Immunol 34, 469-477 (2014).
33. Yang, J. et al. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr J 60, 185-189 (2013).
34. Sing, G. K. & Ruscetti, F. W. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75, 1965-1973 (1990).
35. Bader-Meunier, B. et al. Varicella-Associated pancytopenia. Eur J Pediatr 149, 810-811 (1990).
36. Ganz, T., Metcalf, J. A., Gallin, J. I., Boxer, L. A. & Lehrer, R. I. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest 82, 552-556 (1988).
37. Gombart, A. F. et al. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon. Blood 97, 2561-2567 (2001).
38. Summers, C. et al. Neutrophil kinetics in health and disease. Trends Immunol 31, 318-324 (2010).
39. Devi, S. et al. Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J Exp Med 210, 2321-2336 (2013).
40. Masri-Iraqi, H., Robenshtok, E., Tzvetov, G., Manistersky, Y. & Shimon, I. Elevated white blood cell counts in Cushings disease: association with hypercortisolism. Pituitary 17, 436-440 (2014).
41. Sorensen, O., Bratt, T., Johnsen, A. H., Madsen, M. T. & Borregaard, N. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J Biol Chem 274, 22445-22451 (1999).
42. Wang, Y., Agerberth, B., Lothgren, A., Almstedt, A. & Johansson, J. Apolipoprotein A-I binds and inhibits the human antibacterial/ cytotoxic peptide LL-37. J Biol Chem 273, 33115-33118 (1998).